-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Sector Perform on Sangamo Therapeutics, Maintains $2 Price Target

Benzinga·03/18/2025 15:41:42
Listen to the news
RBC Capital analyst Luca Issi reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Sector Perform and maintains $2 price target.